Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Biosimilars, Technology and Equipment

Open Your Mind

It is universally acknowledged that the pharmaceutical industry can be conservative and slow to embrace change. With the health and safety of patients at stake if something should go wrong, this is hardly surprising. But does pharma’s skepticism run too deep?

I recently had the pleasure of speaking with Alex Zhavoronkov, CEO of Insilico Medicine – a passionate supporter of artificial intelligence (read more here) and a true believer of its transformative potential in drug discovery. Insilico Medicine is working with Juvenescence to identify preclinical compounds, but there are other companies grabbing headlines in the AI/pharma space; take BenevolentAI, which is attempting to gain new insight into the molecular mechanisms of disease and to match patients to the right drug. The company was valued at $2 billion after its latest round of funding (1).

Roisin McGuigan

Deputy Editor

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as a Deputy Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register